Journal: Oncotarget

Article Title: CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid

doi:

Figure Lengend Snippet: the expression patterns of CRABP-II and FABP5 in different grades of human astrocytomas

Article Snippet: The antibodies used were rabbit anti-human CRABP II and rabbit anti-human FABP5 (Proteintech, Chicago, IL, USA) at dilutions of 1:100 and 1:80, respectively.

Techniques: Expressing

Journal: Oncotarget

Article Title: CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid

doi:

Figure Lengend Snippet: The staining patterns were scored as “−” if no immunolabeling was observed in the cells and “+” if distinct staining was generally observed. (A) Immunohistochemical profiling of CRABP-II and FABP5 expression patterns in non-tumor brain tissues and glioblastomas. (B) The percentage of CRABP-II and FABP5 expression in the four astrocytoma grades.

Article Snippet: The antibodies used were rabbit anti-human CRABP II and rabbit anti-human FABP5 (Proteintech, Chicago, IL, USA) at dilutions of 1:100 and 1:80, respectively.

Techniques: Staining, Immunolabeling, Immunohistochemical staining, Expressing

Journal: Oncotarget

Article Title: CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid

doi:

Figure Lengend Snippet: (A) Immunocytochemical staining of CRABP-II and FABP5 expression in the three cell lines that were either untreated (N) or treated with RA (RA). (B) RT-PCR and western blot analyses of CRABP-II and FABP5 expression in LN18, LN428 and U251 cells with and without RA treatment. CRABP-II/FABP5 ratios were calculated according to the results of RT-PCR and western blotting.

Article Snippet: The antibodies used were rabbit anti-human CRABP II and rabbit anti-human FABP5 (Proteintech, Chicago, IL, USA) at dilutions of 1:100 and 1:80, respectively.

Techniques: Staining, Expressing, Reverse Transcription Polymerase Chain Reaction, Western Blot

Journal: Oncotarget

Article Title: CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid

doi:

Figure Lengend Snippet: (A) RT-PCR examination of CRABP-II, FABP5, RARβ, OLFM4, PPARγ and CYP26A1 transcription under the following conditions: normal culture, 10 μM of RA for 48 h, 1 μM decitabine for 72 h and 10 μM of RA for 48 h after pre-treatment with 1 μM decitabine for 72 h. CRABP-II/FABP5 ratios were calculated according to RT-PCR data. (B) CRABP-II and FABP5 western blotting performed on LN18, LN428 and U251 cells under the following conditions: normal culture, 10 μM of RA for 48 h and 1 μM decitabine pretreatment for 72 h followed by 10 μM of RA for 48 h. CRABP-II/FABP5 ratios were calculated according to the data obtained.

Article Snippet: The antibodies used were rabbit anti-human CRABP II and rabbit anti-human FABP5 (Proteintech, Chicago, IL, USA) at dilutions of 1:100 and 1:80, respectively.

Techniques: Reverse Transcription Polymerase Chain Reaction, Western Blot

Journal: Oncotarget

Article Title: CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid

doi:

Figure Lengend Snippet: Primer sequences, amplicon size and annealing temperature for RT-PCR

Article Snippet: The antibodies used were rabbit anti-human CRABP II and rabbit anti-human FABP5 (Proteintech, Chicago, IL, USA) at dilutions of 1:100 and 1:80, respectively.

Techniques: Amplification